To this end, we conducted an in vitro study to evaluate the impact of COMP-4 in a human arterial endothelial cell line with or without endothelial dysfunction, with a focus on cGMP expression, NO activity, NOS expression, and PAI-1 activity. The gene discussed is NOS2; the disease is endothelial dysfunction.